A new strategy for the prevention of atrial fibrillation : HCN channel blockers
A new strategy for the prevention of atrial fibrillation : HCN channel blockers
批准号:
13672382
负责人:
UEMURA Hiroko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Recently a second distinct mechanism causing atrial fibrillation has been recognized ; a rapidly firing focus (foci), usually located in or near the pulmonary veins (PVs). From the morphology of the action potential recorded from PV, a slow diastolic depolarization appears to be involved in the generation of the spontaneous activity. It is acknowledged that the hyperpolarization-activated inward current called I_h or I_f plays an important role in the pacemaker activity of cardiac cells. Recently a new family of the hyperpolarization-activated cyclic-nucleotide cation channels has been cloned (HCN1, 2, 3, 4). HCN4 appears to be a dominant one among the isoforms in cardiac tissues. The first aim of the present study was to determine whether HCN4 channels distribute in the junction of PVs and atrial tissues of rat by immunohistochemical staining. The second aim of this study was to examine several antiarrhythmic drugs on the HCN4 channel current expressed in mammalian (HEK293) cells and spontaneous activity of PV atriai preparations.Immunohistochemical staining with ant-HCN4 antibody was observed at the boundary of PV and atrial tissues. HCN4 channels were stably expressed in HEK293 cells and effects of various drugs on the current were examined by using patch clamp techniques. The HCN4 channel current was significantly inhibited by zatebradine, amiodarone and bepridil. Other antiarrhythmic drugs such as quinidine, lidocaine, aprindine and flecainide also inhibited the HCN4 channel current although they were less potent than amiodarone or bepridil. Spontaneous activity in isolated PV-atrial preparations of the rat was accelerated by isoproterenol and suppressed by zatebradine or antiarrhythmic drugs.The inhibition of the HCN channels by antiarrhythmic drugs may lead to the prevention of paroxysmal atrial fibrillation triggered by ectopic foci at the boundary of PV and atrial tissues.
期刊论文(73)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
中谷晴昭: "アミオダロンのマルチチャネル遮断作用とその電気薬理学的意義"Progress in Medicine. 21. 257-262 (2001)
Haruaki Nakatani:“胺碘酮的多通道阻断作用及其电药理学意义”医学进展 21. 257-262 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kushida S.: "Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels : mode of action"Eur. J. Pharmacol.. 457. 19-27 (2002)
Kushida S.:“III 类抗心律失常药物尼非卡兰对 HERG 通道的抑制作用:作用方式”Eur。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Furukawa T.: "Phosphorylation and functional regulation of CIC-2 chloride channels expressed in Xenopus oocytes by M cyclin-dependent protein kinase"J. Physiol.. 540. 883-893 (2002)
Furukawa T.:“M 细胞周期蛋白依赖性蛋白激酶对爪蟾卵母细胞中表达的 CIC-2 氯通道的磷酸化和功能调节”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
中谷晴昭: "看護に役立つ薬理学の視点"看護. 54. 044-047 (2002)
Haruaki Nakatani:“对护理有用的药理学观点”护理 54. 044-047 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
中谷晴昭: "薬剤誘発性QT延長症候群と創薬"治療学. 35. 24-24 (2001)
Haruaki Nakatani:“药物引起的长 QT 综合征和药物发现”《治疗学》35. 24-24 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
Functional roles of vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice.
-
批准号:11672255
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.64万
-
财政年份:1999
-
负责人:UEMURA Hiroko
-
依托单位:
Electropharmacological analysis of the regulation of the cardiac K^+ channels by inositol trisphosphate.
-
批准号:09670089
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1997
-
负责人:UEMURA Hiroko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
增龄性房颤中DCAF15结合LRMP活化HCN4促进心房兴奋性的机制研究
-
批准号:
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2024
-
负责人:李耀东
-
依托单位:
LMNA p.R335W 突变通过表观遗传学重构下调HCN4导致家族性窦
房结功能障碍的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张易轲
-
依托单位:
HCN4基因变异介导心肌细胞钙稳态失衡在SUNDS中的致病作用机制研究
-
批准号:82101973
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:吴秋萍
-
依托单位:
NUP155通过转录因子NKX2.5调控HCN4和KCNQ1诱发房颤机理研究
-
批准号:82100340
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王龙飞
-
依托单位:
元姜方通过节律钟相关基因BMAL1/SCN5A/HCN4提高窦房结自律性的机制研究
-
批准号:82004352
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:张菀桐
-
依托单位:
脊髓背角 HCN4 - KCC2 在糖尿病性神经痛中作用的研究
-
批准号:81960161
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:刘晓红
-
依托单位:
Tbx3优化HCN4转染诱导多能干细胞重建心脏生物起搏点的相关研究
-
批准号:81873486
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:周亚峰
-
依托单位:
敲除NKx2.5联合Shox2与HCN4双基因转染猪VSELs细胞构建生物起搏器
-
批准号:81800250
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2018
-
负责人:朱业
-
依托单位:
HCN4和Cx45基因联合转染骨髓间充质干细胞构建生物起搏细胞治疗缓慢型心律失常的实验研究
-
批准号:81770327
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:李红霞
-
依托单位:
基于慢病毒载体转染HCN4通道基因探讨参附注射液动员MSCs重建窦房结起搏功能的研究
-
批准号:81774260
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:李荣
-
依托单位: